Form 8-K - Current report:
SEC Accession No. 0001641172-25-014525
Filing Date
2025-06-10
Accepted
2025-06-10 16:30:22
Documents
14
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46184
2 EX-99.1 ex99-1.htm EX-99.1 7820
  Complete submission text file 0001641172-25-014525.txt   268623

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20250610.xsd EX-101.SCH 3891
4 XBRL DEFINITION FILE celu-20250610_def.xml EX-101.DEF 26798
5 XBRL LABEL FILE celu-20250610_lab.xml EX-101.LAB 37062
6 XBRL PRESENTATION FILE celu-20250610_pre.xml EX-101.PRE 25422
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6064
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 251037521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)